| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |